Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Change in Cash: 2023-2025

Historic Change in Cash for Zenas BioPharma (ZBIO) over the last 2 years, with Sep 2025 value amounting to $71.6 million.

  • Zenas BioPharma's Change in Cash fell 59.37% to $71.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$244.6 million, marking a year-over-year decrease of 185.00%. This contributed to the annual value of $262.9 million for FY2024, which is 2639.50% up from last year.
  • According to the latest figures from Q3 2025, Zenas BioPharma's Change in Cash is $71.6 million, which was up 146.91% from -$152.5 million recorded in Q2 2025.
  • In the past 5 years, Zenas BioPharma's Change in Cash ranged from a high of $176.1 million in Q3 2024 and a low of -$152.5 million during Q2 2025.
  • For the 3-year period, Zenas BioPharma's Change in Cash averaged around $5.4 million, with its median value being -$17.6 million (2023).
  • Data for Zenas BioPharma's Change in Cash shows a maximum YoY tumbled of 525.71% (in 2025) over the last 5 years.
  • Zenas BioPharma's Change in Cash (Quarterly) stood at -$15.5 million in 2023, then plummeted by 160.74% to -$40.3 million in 2024, then crashed by 59.37% to $71.6 million in 2025.
  • Its Change in Cash stands at $71.6 million for Q3 2025, versus -$152.5 million for Q2 2025 and -$123.3 million for Q1 2025.